J&J Units Aim To Hit Brakes On Generic Schizophrenia Drug
Johnson & Johnson units have slammed Intas Pharmaceuticals Ltd. with a patent suit in New Jersey federal court seeking to block the India-based drugmaker from selling a generic version of the...To view the full article, register now.
Already a subscriber? Click here to view full article